The 2025 ASCO Annual Meeting highlighted several groundbreaking developments across the landscape of breast cancer research, from early detection to cutting-edge treatments. These advances offer hope to individuals diagnosed at every stage of breast cancer, from early-stage disease to metastatic breast cancer (MBC). In this episode of Breast Cancer Breakthroughs, we speak with Dawn Hershman, […] The post Breast Cancer Breakthroughs Episode 14: Highlights from ASCO 2025 appeared first on...| Susan G. Komen®
After Shawna Bramel received a diagnosis of triple negative breast cancer (TNBC), she described the empowerment that came with knowledge: “I researched everything and familiarized myself with treatment options so I could make informed decisions for myself.” Like Shawna, many people feel more in control when they understand what makes their type of breast cancer […] The post Triple Negative Breast Cancer (TNBC): What to Know After a Diagnosis appeared first on Susan G. Komen®.| Susan G. Komen®
Take a look at some of the top biotech companies you can find in Spain, whose biotech industry has grown dramatically in the last decade. The post 10 biotech companies you should know about in Spain appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given ...| Labiotech.eu
Demand for next-generation GLP-1 drugs is fueling a boom in peptide research, prompting companies like Sai Life Sciences to expand capabilities amid a hot market for obesity and diabetes treatments. “The GLP-1 agonists have exploded the peptide field,” said Maneesh Pingle, Ph.D., executive vice president and head of discovery services at Sai Life Sciences, in… The post Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center appeared first on Drug...| Drug Discovery and Development